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ABSTRACT: The aim of the present study was to analyse the risk of rehospitalisation in patients
with chronic obstructive pulmonary disease and associated risk factors.
This prospective study included 416 patients from a university hospital in each of the five Nordic
countries. Data included demographic information, spirometry, comorbidity and 12 month follow-
up for 406 patients. The hospital anxiety and depression scale and St. George’s Respiratory
Questionnaire (SGRQ) were applied to all patients.
The number of patients that had a re-admission within 12 months was 246 (60.6%). Patients that
had a re-admission had lower lung function and health status. A low forced expiratory volume in
one second (FEV1) and health status were independent predictors for re-admission. Hazard ratio
(HR; 95% CI) was 0.82 (0.74–0.90) per 10% increase of the predicted FEV1 and 1.06 (1.02–1.10) per
4 units increase in total SGRQ score. The risk of rehospitalisation was also increased in subjects
with anxiety (HR 1.76 (1.16–2.68)) and in subjects with low health status (total SGRQ score .60
units). When comparing the different subscales in the SGRQ, the closest relation between the risk
of rehospitalisation was seen with the activity scale (HR 1.07 (1.03–1.11) per 4 unit increase).
In patients with low health status, anxiety is an important risk factor for rehospitalisation. This
may be important for patient treatment and warrants further studies.
KEYWORDS: Anxiety, chronic obstructive pulmonary disease, depression, health status,
rehospitalisation, risk factors
C
hronic obstructive pulmonary disease
(COPD) is associated with intermittent
exacerbations characterised by acute
deterioration in the symptoms of chronic dys-
pnoea, cough and sputum production. Hospitali-
sations because of acute exacerbations are an
important part of the care of patients with COPD.
They are associated with further impairment of
health status [1], increased mortality [2] and high
costs [3]. Rehospitalisations are common and
occur in up to 60% of patients within 1 yr of the
last exacerbation [4].
Multiple studies have been conducted in order
to identify risk factors for COPD hospitalisa-
tions and there is also an increasing interest in
modifying the risk factors in order to reduce
the rate of rehospitalisation [5]. Risk factors
that have been identified in previous studies
are as follows: 1) low lung function [4, 6, 7];
2) increasing age [7]; 3) poor quality of life
[1, 8, 9]; 4) low physical function [4, 8]; 5)
history of frequent past exacerbations [1]; 6)
history of previous admissions [4, 6]; 7) under
prescription of long-term oxygen therapy [6]; 8)
hypercapnoea; and 9) pulmonary hypertension
[10]. Interventions that decrease the risk of
hospitalisations in COPD patients include
vaccinations for influenza [11], smoking cessa-
tion [12] and pulmonary rehabilitation [13]. A
study by DAHLE´N and JANSON [14] found that
anxiety and depression were related to a
higher risk of relapse in patients with asthma
and COPD that were admitted for emergency
treatment. There is, however, limited data
available regarding the level of anxiety and
depression and the risk for hospital re-admis-
sion for COPD. There is also a lack of data on
re-admission rates of COPD from Northern
Europe and many previous studies have
included data on mostly male populations.
The aim of the present study was to analyse the
risk of rehospitalisation in patients with COPD
and associated risk factors with special emphasis
on health status, anxiety and depression.
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MATERIALS AND METHODS
This was a prospective study of patients hospitalised with
acute exacerbations of obstructive airway disease in five
university hospitals in the Nordic countries. The departments
included were: Dept of Respiratory Medicine and Allergology,
Akademiska sjukhuset, Uppsala, Sweden; Dept of Thoracic
Medicine, Haukeland University Hospital, Bergen, Norway;
Dept of Respiratory Medicine, Tampere University Hospital,
Tampere, Finland; Dept of Respiratory Medicine, Allergy and
Sleep, Vifilstadir University Hospital, Gardabaer, Iceland;
and Dept of Respiratory Medicine, Hvidovre Hospital,
Copenhagen, Denmark. The study was approved by the
Institute Review Board and/or an ethic committee for each
institution or country. Informed consent was obtained from
all the patients.
Consecutive patients from each of the participating hospitals
were included provided that they had been admitted with
acute exacerbations of obstructive lung disease (asthma,
chronic bronchitis, chronic obstructive bronchitis or emphy-
sema) during the year 2000–2001. An acute exacerbation was
defined as a change in condition in a COPD patient from
baseline of such a magnitude that it needed an acute hospital
admission. In the following analysis all patients with asthma
were excluded. The reported data are only from those fulfilling
criteria for COPD according to the Global initiative for chronic
Obstructive Pulmonary Disease (GOLD) stage I or higher [15].
Codes from International classification of diseases-10 for
COPD were used. All records were reviewed by the
investigators to confirm the diagnosis. Only patients that were
admitted for .24 h were included. All information was
collected by the same person in each country who had
received basic training. The same person carried out the initial
and follow-up information collection in each country.
The following data were collected at discharge from the
respective pulmonary departments. 1) A questionnaire that
included information on smoking history, type of living and
family situation (alone or with others) in addition to educa-
tional level. 2) Spirometry, body weight and height. Predicted
values for forced expiratory volume in one second (FEV1) and
forced vital capacity were calculated based on the European
Coal and Steel Union reference values [16]. 3) Health status
was assessed using the disease-specific St George’s Respiratory
Questionnaire (SGRQ). It has three components (symptoms,
activity and impact) in addition to total score [17]. Higher
scores indicate a worse health status. Anxiety and depression
were evaluated using the Hospital Anxiety and Depression
scale (HAD) [18], which is self-reported and has been used
extensively to screen psychiatric morbidity. It has high validity
when used as a screening instrument for psychiatric morbidity
[19–21]. It is comprised of two parts, the first with seven
questions related to anxiety and the second with seven
questions related to depression. A score of eight or more on
either part was used as the cut-off point for diagnosing anxiety
and depression, respectively [18]. 4) From the patient records
information was collected on treatment at discharge, including
long-term oxygen therapy. Assessment of comorbidity was
based on the diagnosis used by the treating physician. Diabetes
mellitus was considered to be present if using medications for
diabetes. Hypertension, ischemic heart disease or atrial
fibrillation were considered to be present when diagnosed by
an attending physician and the patient was using appropriate
medications. 5) Enrolled patients were contacted by phone 1 yr
after discharge in order to obtain information regarding
number of hospitalisations. This data was confirmed by
checking hospital records. In patients that had died before
the follow-up, information on hospitalisations was collected
through hospital records.
STATISTICS
The Chi-squared test and an unpaired t-test were used when
comparing patients that had or had not been hospitalised
during the study period.
The time until re-admission was analysed by the Kaplan-Meier
survival analysis and Cox regression. In the Cox regression
analysis the total HAD score was used together with all the
other independent variables in one model. Separate estimates
were then calculated for the HAD anxiety subscales, keeping
all other variables except the total HAD score in the model. The
estimation of the relation between the risk of rehospitalisation
on the HAD depression scale was calculated in a similar
fashion in a third model.
Linear regression was used to analyse the relationship between
health status and psychological status. In order to detect
heterogeneity between the hospitals concerning determinants
for rehospitalisation the Cox regression estimates (hazard ratio
(HR)) were also calculated by the hospital and then combined,
using random effect meta-analysis. A p-value of ,0.05 was
considered statistically significant.
RESULTS
In total, 416 consecutive patients with COPD were enrolled in
the study and re-admission data up to 1 yr was available for
406 subjects. During the study period 57 patients died. Of
these, 42 had a recorded rehospitalisation due to a COPD
exacerbation before dying, nine had no recorded COPD
rehospitalisation and six were lost to follow-up. The number
of patients that had a re-admission within 12 months was 246
(60.6%).
Table 1 compares the characteristics of the patients included in
relation with re-admission. There was no significant difference
between the groups regarding anxiety and depression. Patients
who had a re-admission had lower health status with higher
SGRQ scores for activity (mean¡SD; 73¡18 versus. 59¡23) and
impact (50¡19 versus 41¡19; fig. 1). Those with re-admission
had lower lung function, were more often using long-term
oxygen and had a higher number of COPD hospitalisations in
the previous 12 months than patients without re-admission
(table 1). Patients with rehospitalisations were more often
using nebulised therapy and oral theophyllines and less often
inhaled anticholinergics on discharge from hospital than
subjects that did not have re-admissions (table 1). A significant
relationship was found between COPD severity (fig. 2) and
health status (fig. 3), as well as the time of re-admission when
this was analysed by Kaplan-Meier survival analysis.
No association was found between psychological status and
re-admissions when analysing data from all subjects. A
significant correlation was, however, found between the total
SGRQ score and the total HAD score (r50.38; p,0.0001). Using
the median of the total SGRQ score the patients were divided
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into patients with higher (total SGRQ score f60 units) and
lower (total SGRQ .60 units) health status. There was a
significant interaction between health status and psychological
status in relation to the risk of re-admission (p50.002) with a
significant correlation between the total HAD score and the
risk of re-admission in patients with a low health status
(table 2). In the groups of subjects with low health status,
higher anxiety score was related to increased risk of
TABLE 1 Characteristics of patients included in the study in relation to re-admission
All No rehospitalisation Rehospitalisation p-value
Subjects n 406 160 246
Age yrs 69.2¡10.5 68.3¡12.1 69.8¡9.4 0.16
Female 51.2 54.4 49.2 0.31
Hospital stay days 8 (6–13) 7 (5–12) 9 (6–14) 0.02
Smokers 36.0 30.6 23.0 0.09
Pack-yrs 35.2¡23.3 33.9¡21.2 36.1¡24.6 0.37
College education 30.7 30.8 30.6 0.96
Living alone 52.1 48.7 54.4 0.28
COPD hospitalisations in last 12 months 1 (0–3) 0.5 (0–1) 1 (1–3) ,0.0001
HAD-Total 12.5¡6.8 12.1¡6.3 12.7¡7.1 0.38
HAD-Anxiety 7.0¡4.2 6.7¡4.0 7.1¡4.3 0.28
HAD-Depression 5.5¡3.6 5.4¡3.4 5.6¡3.8 0.63
Anxiety 41.0 39.5 42.1 0.61
Depression 28.7 26.5 30.2 0.44
Health status SGRQ total score 58¡17 52¡17 62¡16 ,0.0001
FEV1 % pred 38.4¡18.2 44.8¡19.4 34.1¡15.9 ,0.0001
FVC % of pred 61.8¡19.2 66.2¡19.2 58.8¡20.7 0.0005
Long-term oxygen 23.6 16.2 28.4 0.005
Cardiovascular diseases 44.6 45.6 43.9 0.76
Diabetes 10.3 7.5 12.2 0.13
Anticholinergics 35.8 43.6 30.7 0.009
Short acting b2-agonists 35.9 33.8 37.3 0.53
Long acting b2-agonists 61.4 60.5 61.9 0.78
Inhaled corticosteroids 69.9 69.9 70.0 0.98
Nebulised treatment 33.2 19.9 41.8 ,0.0001
Oral theophylline 27.7 19.7 32.9 0.004
Oral corticosteroids 65.7 62.4 67.9 0.26
Data presented as n, mean¡SD, median (interquartile range) or %. COPD: chronic obstructive pulmonary disease; HAD: hospital anxiety and depression scale; SGRQ: St
George’s Respiratory Questionnaire; FEV1: forced expiratory volume in one second; FVC: forced vital capacity. Chi-squared test and unpaired t-tests was used to
calculate the p-values.
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FIGURE 1. Health status in relation to patients with (&) and without (h)
hospital re-admissions. The box plot displays the median, 10, 25, 50, 75 and 90%
percentiles. #: p50.08; ": p,0.0001.
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FIGURE 2. Kaplan-Meier survival curve demonstrating the time until re-
admission in patients in relation to chronic obstructive pulmonary disease (COPD)
severity defined according to the Global initiative for chronic Obstructive Lung Disease
(GOLD) classification. –––: GOLD I and II; ? ? ?: GOLD III; - - -: GOLD IV. p,0.0001.
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rehospitalisation. No significant relationship between depres-
sion score and the risk of rehospitalisation was found
regardless of health status (table 2).
FEV1 and health status were independent predictors for re-
admission in the multivariable analysis (table 2). Previous
hospitalisations were also independently related to an
increased risk of rehospitalisation for at least two previous
hospitalisations (HR (95% confidence interval (CI)): 1.98 (1.42–
2.76)). Including previous hospitalisations, however, did not
change the relationship between FEV1, health status and the
risk of rehospitalisations.
There was no change in the associations between FEV1,
health status, psychological status and the risk of rehospi-
talisation after adding in the pharmacological treatment.
None of the different types of treatment were significantly
associated with re-admission after adjusting for the other
covariables.
When comparing the different subscales in the SGRQ, no
association was found between the symptom scale and re-
admission (HR (95% CI) for a 4 unit increase 1.01 (0.98–1.05)),
while a significantly increased risk for re-admissions was
found both for the impact (1.04 (1.01–1.07)) and the activity
scale (1.07 (1.03–1.11)). There was no significant difference
between the hospitals in the association between risk of re-
admission and FEV1 or health status (p-value for heterogene-
ity50.30 and 0.68, respectively).
DISCUSSION
The main finding of the present prospective multicentre study
was that in COPD patients with low health status being
discharged after hospital admission, the risk of rehospitalisa-
tion was higher in patients with anxiety. A low FEV1 and low
health status were found to be important risk factors for re-
admission.
It is unclear if the prevalence of depression is increased in
COPD patients in general, but the prevalence of anxiety is
increased in COPD patients compared with control groups
[22, 23]. The symptoms of COPD such as breathlessness,
limitation of activity and repeated exacerbations are likely to
cause anxiety in patients with COPD. Cigarette smoking is
also increased in patients with anxiety, thus, psychiatric
disturbance is an aetiologic agent in COPD [24]. Hospitalised
patients with COPD have a high prevalence of depression
and anxiety [25]. The association of depression and anxiety
with risk of rehospitalisation is an area that has not been well
studied previously. In the present study there was a
significant association between anxiety, depression and
health status. In patients who had a low health status a
significant increased risk of rehospitalisations was found in
those patients that had anxiety. It is possible that the low
health status causes anxiety in these patients or that they
were anxious previously. No association was found between
depression and the risk of re-admissions. In contrast to the
current results no association was found with risk of re-
admission using the mental scale of short form (SF)-12 or the
mental health inventory of the SF-36 in the Estudi del Factors
de Risc d’Aguditzacio de la MPOC (EFRAM) study [4]. FAN
et al. [9] found that patients with the lowest scores on the
emotional function skills scale in health status were at
greater risk for rehospitalisation. A study by OKUBADEJO et al.
[26] found that in patients with COPD and severe hypoxemia
the SGRQ total score was related with anxiety and depres-
sion measured by the HAD scale. Multivariate analysis
showed that depression score and arterial oxygen tension
were both significant covariates of the SGRQ total score.
There is lack of standardisation for instruments to detect
anxiety and depression and the definition of anxiety and
depression. The HAD scale was used in the present study
with a previously recognised cut-off score for significant
disease [18]. The current authors have used the HAD scale
previously in a study on a mixed population of asthmatics
and COPD patients where anxiety and depression were
found to increase the risk of relapse after emergency
treatment [14].
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FIGURE 3. Kaplan-Meier survival curve demonstrating time until re-admission
in relation to health status (St George’s Respiratory Questionnaire (SGRQ) total
score).The patients were divided into quartiles according the SGRQ total score.
– ? –: 1st quartile ,46.4; ? ? ?: 2nd quartile 46.4–60.4; - - -: 3rd quartile 60.5–70.5;
–––: 4th quartile .70.6. p,0.0001.
TABLE 2 Determinants for re-admissions analysed by Cox
regression
All subjects SGRQ total
f60
SGRQ total
.60
Subjects n 340 170 170
Age 10 yrs 1.16 (1.00–1.35) 1.14 (0.92–1.419) 1.19 (0.95–1.50)
Current smoker 0.78 (0.55–1.10) 0.69 (0.37–1.29) 0.82 (0.53–1.26)
HAD-total 4 units* 1.03 (0.93–1.13) 0.87 (0.74–1.03) 1.13 (1.01–1.27)
HAD-anxiety 4 units* 1.10 (0.95–1.28) 0.81 (0.63–1.04) 1.36 (1.12–1.65)
HAD-depression
4 units*
0.96 (0.80–1.15) 0.83 (0.61–1.14) 1.02 (0.81–1.28)
Anxiety* 1.06 (0.79–1.41) 0.43 (0.25–0.74) 1.73 (1.18–2.53)
Depression* 1.09 (0.80–1.51) 0.84 (0.46–1.55) 1.20 (0.81–1.79)
FEV1 10% pred 0.83 (0.76–0.91) 0.80 (0.70–0.92) 0.83 (0.53–1.26)
SGRQ-total 4 units 1.06 (1.02–1.11) 1.06 (0.97–1.15) 1.08 (0.98–1.18)
Data presented as n and hazard ratio (95% confidence interval). SGRQ: St
George’s Respiratory Questionnaire; HAD: hospital anxiety and depression
scale; FEV1: forced expiratory volume in one second. *: Entered separately into
the model.
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The present study shows that health status is an important risk
factor for rehospitalisation. This is consistent with previous
studies [1, 8, 9]. OSMAN et al. [8] found that higher scores on the
SGRQ (lower health status) predicted hospital re-admission
within the next 12 months, while sex, age, and pulmonary
function did not.
It is of interest that the association of health status was highest
with the activity score on the SGRQ. The EFRAM study from
Spain showed that higher levels of physical activity reduced
the risk for rehospitalisation [4]. Patients that reported an
activity equivalent to walking for o1 h a day had a reduction
in risk of admission to hospital of almost 50%. The same was
true for those who scored highly on the physical scale of SF-36
[4]. In another study FAN et al. [9] showed that patients with
lowest physical function had an odds ratio of 6.0 for
hospitalisation. It is, therefore, likely that the high score on
activity in the current study, suggesting severe limitation in
activity, shows that deconditioning is a risk factor for COPD
admission.
The results that hospitalised patients with a low FEV1 have a
higher risk of being readmitted is in accordance with several
previous studies that have shown that impaired lung function
is an important risk factor for hospitalisations [4, 6, 7, 27]. As in
previous studies patients with frequent previous hospitalisa-
tions were found to have a higher risk of being rehospitalised
[4, 6, 27].
ROBERTS et al. [27] found that patients with a higher number of
medications and patients using home nebulisers had a higher
risk of re-admission [27]. This probably reflects severity of
disease, with these medications reserved for the patients with
the most severe disease rather than the effect of the medica-
tions. No independent relation was found between pharma-
cological treatment and the risk of re-admissions after
adjusting other covariables such as FEV1, health status and
psychological status. Neither was any relationship found
between socioeconomic variables such as educational level or
home situation and the risk of rehospitalisations.
The re-admission rate of 60% is very similar to other studies.
A retrospective study from Hong Kong on 551 patients
showed a 59.35% re-admission rate after 12 months [28]. In
the prospective EFRAM study, 63% of 340 patients were re-
admitted during the 1yr follow-up time [4].
The strengths of the present study are the large number of
patients included, making it the largest prospective survey
on COPD re-admission ever. Only 10 out of 416 (2%) patients
were lost to follow-up. The study included patients from
five countries, a mixture of males and females and different
GOLD stages. Similar relationships were observed between
the risk factors and COPD re-admission in all the countries.
There were several limitations to the study, including lack of
information on participants versus nonparticipants, and co-
intervention such as nonpharmacological treatments e.g.
rehabilitation and education. The HAD questionnaire is
fairly short and naturally has some limitation in diagnosing
anxiety and depression. The instrument has, however, in
previous studies been shown to have a fairly high validity
when used as a screening instrument for psychiatric
morbidity [19–21].
In conclusion, psychological status is important in patients
with chronic obstructive pulmonary disease. There is a clear
association between health status and anxiety and depression,
and an increased risk of rehospitalisations in patients with
anxiety who have a low health status. This adds important new
information in the treatment of hospitalised patients with
chronic obstructive pulmonary disease and on the risk factors
of rehospitalisation. Further studies are necessary to observe if
treatment of anxiety can reduce the rate of rehospitalisation in
patients with chronic obstructive pulmonary disease. Lung
function and health status are the most important risk factors
for re-admission and the present study underlines the high re-
admission rates for patients admitted for chronic obstructive
pulmonary disease exacerbation within 1yr.
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